Tumores Gastrintestinais
M-A | Comparação entre desfechos de quimiorradioterapia neoadjuvante e quimioterapia neoadjuvante em pacientes com câncer esofágico localmente avançado.
8 Nov, 2021 | 12:24hRevisão | Manejo clínico de lesões pancreáticas pré-malignas.
1 Nov, 2021 | 10:51hClinical Management of Pancreatic Premalignant Lesions – Gastroenterology
Estudo randomizado | Gastrectomia distal laparoscópica vs. aberta para câncer gástrico localmente avançado.
26 Out, 2021 | 11:20hLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Comentário no Twitter
It is not clear whether laparoscopic (LDG) and open distal gastrectomy (ODG) produce similar long-term outcomes in advanced #gastriccancer. CLASS-01 trial firstly shows LDG results in similar 5-year OS compared to ODG in advanced gastric cancer https://t.co/uUBcLFeqsY
— JAMA Surgery (@JAMASurgery) October 20, 2021
Estudo randomizado | Entre pacientes com câncer colorretal metastático, os randomizados para tratamento sistêmico isolado tiveram menor mortalidade em 60 dias do que aqueles randomizados para ressecção de tumor primário seguida de tratamento sistêmico.
13 Out, 2021 | 12:35hSixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Editorial: Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials – JAMA Surgery (gratuito por tempo limitado)
Comentário: Systemic Therapy Alone Bests Surgical Tx for Metastatic CRC – BreakingMed
Comentário no Twitter
Early mortality in patients with colorectal cancer and unresectable metastases randomized to primary tumor resection followed by systemic treatment is considerably higher than early mortality in patients randomized to systemic treatment only https://t.co/SyfYjmDU7i @DaveKruijssen
— JAMA Surgery (@JAMASurgery) October 11, 2021
Estudo randomizado | Bloqueio neurolítico de nervo esplâncnico e alívio da dor, sobrevida e qualidade de vida no câncer pancreático irressecável.
1 Out, 2021 | 20:14h
Comentário no Twitter
Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial https://t.co/xa9sPAdQu1 pic.twitter.com/gi74fdDSfl
— Anesthesiology journal (@_Anesthesiology) August 30, 2021
Diretrizes Clínicas da ESMO–EURACAN–GENTURIS para diagnóstico, tratamento e seguimento de tumores estromais gastrintestinais.
1 Out, 2021 | 20:08hRevisão do Estado de Arte | Rastreamento e prevenção do câncer colorretal.
17 Set, 2021 | 12:33hScreening and prevention of colorectal cancer – The BMJ (gratuito por tempo limitado)
Conteúdos relacionados:
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Diretriz para a vigilância e os cuidados de sobrevivência de pacientes após tratamento curativo de câncer colônico e retal.
17 Set, 2021 | 12:23hConteúdo relacionado: Study: Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
Comentário no Twitter
Clinical Practice Guidelines – Surveillance and Survivorship shown in #DCRJournal visual abstract by @ianmpaquette @JMigaly @ASCRS_1. What do you think? https://t.co/e3kADOerpq@JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD pic.twitter.com/wOhu0Mby60
— DCRjournal (@DCRjournal) May 9, 2021
Diretriz de consenso | Transplante hepático para metástases hepáticas e colorretais não ressecáveis.
17 Set, 2021 | 12:22hLiver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines – The Lancet Gastroenterology & Hepatology (necessário cadastro gratuito)
Comentário no Twitter
New online – Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelineshttps://t.co/oZL4X4h7VS@IHPBA @gbonneysurg @eahpba @_ilts_#livertwitter #APHPBA_2021 pic.twitter.com/g6rrVclV5h
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2021
Estudo randomizado | Efeito do canrelizumabe vs. placebo adicionado à quimioterapia na sobrevida e na sobrevida livre de progressão em pacientes com carcinoma esofágico de células escamosas avançado ou metastático.
17 Set, 2021 | 11:55hEffect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma—Renewed Enthusiasm and a Lingering Challenge – JAMA Oncology (gratuito por tempo limitado)
Comentário no Twitter
Among patients with advanced or metastatic esophageal squamous cell carcinoma, the addition of camrelizumab to chemotherapy, compared with placebo and chemotherapy, significantly improved overall survival and progression-free survival https://t.co/DAlhmtgvv1
— JAMA (@JAMA_current) September 14, 2021


